ZNTL SCHEDULE 13G/A: SEC filing
Zentalis Pharmaceuticals, Inc.
Filed with the SEC on · accession 0000312069-26-000217
ZNTL filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 13, 2026. Zentalis Pharmaceuticals, Inc. filed a Schedule 13G/A, an amendment to a passive ownership disclosure. The stock moved -3.3% by the first close after the filing.
Summary of the filing
Zentalis Pharmaceuticals, Inc. filed a Schedule 13G/A, an amendment to a passive ownership disclosure. The filing indicates a change in a holder's beneficial ownership position, though the specific holder and share amounts are not detailed in the provided text.
Key details
How ZNTL stock reacted
Close before
$4.29
Aug 12, 2026
First close after
-3.26%
$4.15
5 trading days
-10.96%
$3.82
Since filing
-59.91%
$1.72
✦ Ask GOAX AI about this filing — what it means for ZNTL, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ZNTL?
Click hereFrequently asked questions
What did ZNTL file with the SEC on Aug 13, 2026?
ZNTL filed a SCHEDULE 13G/A (SEC filing). Zentalis Pharmaceuticals, Inc. filed a Schedule 13G/A, an amendment to a passive ownership disclosure. The filing indicates a change in a holder's beneficial ownership position, though the specific holder and share amounts are not detailed in the provided text.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did ZNTL stock react to this filing?
ZNTL closed at $4.29 before the filing and $4.15 on Aug 13, 2026 (-3.26%). Five trading days later: $3.82 (-10.96%).
Other ZNTL SEC filings
- SCHEDULE 13G/A · SEC filingOct 27, 2026
- SCHEDULE 13G/A · SEC filingAug 19, 2026
- 8-K · Secondary offeringAug 14, 2026
- 424B5 · Secondary offeringAug 14, 2026
- 424B5 · Secondary offeringAug 13, 2026
- 8-K · SEC filingAug 6, 2026
- 10-Q · SEC filingAug 6, 2026
- 8-K · SEC filingJun 18, 2026
- 8-K · SEC filingMay 27, 2026
- 8-K · Fda approvalMay 21, 2026
Get alerts when ZNTL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days